Johnson & Johnson
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American […]
Read More
Study links talc use to ovarian cancer — a potential boon for thousands suing J&J
In this photo illustration a bottle of Johnson & Johnson baby powder is displayed on a table on November 12, 2021 in San Anselmo, California. Justin Sullivan | Getty Images New research published this week lends credence to the more than 50,000 lawsuits against Johnson & Johnson that allege its talc-based baby powder caused ovarian cancer. The analysis, […]
Read More
Stocks generating the most important moves premarket: GameStop, Nvidia, Intel, Kenvue and additional
Look at out the businesses creating headlines just before the bell. GameStop — GameStop shares rallied additional than 37% in the premarket after “Roaring Kitty” posted for the initially time in about 3 a long time . The write-up, a image on X of a video clip gamer leaning ahead on their chair as to […]
Read More
Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & Johnson on Wednesday said it will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management. More CNBC health coverage It […]
Read More
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal challenges to the Biden administration’s Medicare drug-price negotiations, ruling that the program is constitutional. The decision is another win for the White House in a bitter legal fight with several drugmakers […]
Read More
Shares making the biggest moves midday: UnitedHealth, SolarEdge, Financial institution of The usa, Tesla and much more
Test out the corporations making headlines in midday trading. UnitedHealth — Shares climbed additional than 6%, solitary-handedly pushing the Dow Jones Industrial Average higher on Tuesday. UnitedHealth posted superior-than-predicted first-quarter profits and reaffirmed its total-yr earnings forecast of $27.50 to $28 for every share excluding things. Analysts polled by FactSet forecast $27.50. Johnson & Johnson […]
Read More
Shares building the most important moves premarket: Morgan Stanley, UnitedHealth, Are living Country and far more
Verify out the organizations making headlines just before the bell. UnitedHealth — Shares popped about 7% after the health care giant posted improved-than-anticipated profits in its initial-quarter benefits on Tuesday, with growth of near to 9% from $91.9 billion in the exact interval past calendar year. UnitedHealth reported altered earnings of $6.91 per share on revenue […]
Read More
Johnson & Johnson tops quarterly profit estimates as medical device sales jump
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Tuesday reported first-quarter adjusted earnings that topped Wall Street’s expectations as sales in its medical devices business surged. Meanwhile, the company’s total revenue for the […]
Read More
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
Jonathan Raa | Nurphoto | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Hi folks! Two competing cell therapies from Bristol Myers Squibb and Johnson & Johnson both got good news from the Food and Drug Administration on Friday. But J&J’s drug is […]
Read More
We're buying more of this health-care company amid an overdone sell-off
Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, increasing our weighting in the portfolio to 2.42% from 1.95%. We are buying more Abbott Laboratories into its recent weakness as we continue to believe […]
Read More